Please login to the form below

Not currently logged in
Email:
Password:

Alecensa

This page shows the latest Alecensa news and features for those working in and with pharma, biotech and healthcare.

Roche announces positive phase 3 results for Alecensa in early-stage lung cancer

Roche announces positive phase 3 results for Alecensa in early-stage lung cancer

NSCLC). Alecensa was shown to reduce the risk of disease recurrence by 76% compared with platinum-based chemotherapy, Roche said. ... Alecensa is already approved in over 100 countries as a first-line treatment for ALK-positive, metastatic NSCLC.

Latest news

More from news
Approximately 18 fully matching, plus 24 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...
The problem with clinical trials (and how virtual insight-gathering can help)
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
The rise of digital healthcare – fuelled by open innovation in healthtech hubs
How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...